Live news related to DBV TECHNOLOGIES stock (FR0010417345): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The Châtillon-based biotech is among the best performers of the SBF 120 mid-morning, bucking a slightly red index. The announcement of the submission …
The Châtillon-based biotech company has advanced a regulatory milestone in the United States by submitting to the FDA a license application for its pe…
The biotech company specializing in immunotherapy against food allergies is among the strongest declines in the SBF 120 this Tuesday, in a nearly stab…
The Châtillon biotech is recovering somewhat on Monday, posting a modest rebound in a nearly stable SBF 120. The stock nonetheless remains anchored be…
The Châtillon biotech is losing ground this Thursday morning, in a generally declining Paris market. The stock is reverting to selling pressure after …
The Châtillon biotech is resisting mounting pressure on its monthly performance, posting one of the strongest gains in the broad index on Wednesday. T…
DBV Technologies ranks among the strongest gainers on a downward-trending SBF 120 this Friday, posting one of the rare positive performances in the br…
The Châtillon biotech company posts a strong rebound at the end of Thursday, September 17, standing out in a moderately rising SBF 120. The movement c…
The Châtillon biotech resists the turbulent macro environment on this Wednesday, driven by a rebound that erases some of its recent selling pressure. …
The Châtillon biotech company has turned negative again this Friday, following a rebound recorded on Wednesday, September 2. The stock is testing its …
